Immunopathogenesis of idiopathic nephrotic syndrome with relapse

Recent Progress in the Pathophysiology and Treatment of FSGS Recurrence

(2013) P. Cravedi et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Serum Soluble Urokinase-Type Plasminogen Activator Receptor Levels and Idiopathic FSGS in Children: A Single-Center Report

(2013) M. E. Bock et al.   Clinical Journal of the American Society of Nephrology

Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor–dependent idiopathic nephrotic syndrome

(2013) Pietro Ravani et al.   KIDNEY INTERNATIONAL

Upregulation of c-mip is closely related to podocyte dysfunction in membranous nephropathy

(2013) Kelhia Sendeyo et al.   KIDNEY INTERNATIONAL

Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease

(2013) Helene Munyentwali et al.   KIDNEY INTERNATIONAL

Urine But Not Serum Soluble Urokinase Receptor (suPAR) May Identify Cases of Recurrent FSGS in Kidney Transplant Candidates

(2013) Carlos R. Franco Palacios et al.   TRANSPLANTATION

c-mip Down-Regulates NF-κB Activity and Promotes Apoptosis in Podocytes

(2012) Virginie Ory et al.   AMERICAN JOURNAL OF PATHOLOGY

Onco-Nephrology: Glomerular Diseases with Cancer

(2012) J.-F. Cambier et al.   Clinical Journal of the American Society of Nephrology

Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy

(2012) Akira Mima et al.   FASEB JOURNAL

Direct Regulation of Nephrin Tyrosine Phosphorylation by Nck Adaptor Proteins

(2012) Laura A. New et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Circulating suPAR in Two Cohorts of Primary FSGS

(2012) C. Wei et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Rituximab in Children with Resistant Idiopathic Nephrotic Syndrome

(2012) A. Magnasco et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Serum-soluble urokinase receptor concentration in primary FSGS

(2012) Rutger J.H. Maas et al.   KIDNEY INTERNATIONAL

Angiopoietin-like 4: a decade of research

(2011) Pengcheng Zhu et al.   BIOSCIENCE REPORTS

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

(2011) Changli Wei et al.   NATURE MEDICINE

Messenger RNA expression of B7-1 and NPHS1 in urinary sediment could be useful to differentiate between minimal-change disease and focal segmental glomerulosclerosis in adult patients

(2011) Maribel Navarro-Muñoz et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Rituximab Targets Podocytes in Recurrent Focal Segmental Glomerulosclerosis

(2011) A. Fornoni et al.   Science Translational Medicine

Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes

(2010) V. Audard et al.   BLOOD

Circulating Permeability Factors in Idiopathic Nephrotic Syndrome and Focal Segmental Glomerulosclerosis

(2010) E. T. McCarthy et al.   Clinical Journal of the American Society of Nephrology

Recurrent glomerular disease after kidney transplantation

(2010) Todd Fairhead et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population

(2010) J. Eugen-Olsen et al.   JOURNAL OF INTERNAL MEDICINE

Glomerular Structure and Function Require Paracrine, Not Autocrine, VEGF-VEGFR-2 Signaling

(2010) K. Sison et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis

(2010) Eduardo H. Garin et al.   KIDNEY INTERNATIONAL

Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease

(2010) Delma Veron et al.   KIDNEY INTERNATIONAL

Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome

(2010) Lionel C Clement et al.   NATURE MEDICINE

c-mip Impairs Podocyte Proximal Signaling and Induces Heavy Proteinuria

(2010) S. y. Zhang et al.   Science Signaling

Therapeutic approach to focal and segmental glomerulosclerosis recurrence in kidney transplant recipients

(2010) Guillaume Canaud et al.   Transplantation Reviews

VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management

(2009) Hassane Izzedine et al.   EUROPEAN JOURNAL OF CANCER

C-mip interacts with the p85 subunit of PI3 kinase and exerts a dual effect on ERK signaling via the recruitment of Dip1 and DAP kinase

(2009) Maud Kamal et al.   FEBS LETTERS

Angiopoietin-like 4 (ANGPTL4, Fasting-induced Adipose Factor) Is a Direct Glucocorticoid Receptor Target and Participates in Glucocorticoid-regulated Triglyceride Metabolism

(2009) Suneil K. Koliwad et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis

(2009) Elizabeth J Brown et al.   NATURE GENETICS

An overview of small-molecule inhibitors of VEGFR signaling

(2009) S. Percy Ivy et al.   Nature Reviews Clinical Oncology

Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice

(2009) V. Echeverria et al.   NEUROSCIENCE

Urinary CD80 Excretion Increases in Idiopathic Minimal-Change Disease

(2008) E. H. Garin et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Decreased tyrosine phosphorylation of nephrin in rat and human nephrosis

(2008) K. Uchida et al.   KIDNEY INTERNATIONAL

C-mip interacts physically with RelA and inhibits nuclear factor kappa B activity

(2008) Maud Kamal et al.   MOLECULAR IMMUNOLOGY

VEGF Inhibition and Renal Thrombotic Microangiopathy

(2008) Vera Eremina et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases

(2008) Vincent Guigonis et al.   PEDIATRIC NEPHROLOGY